| A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes N Bottini, L Musumeci, A Alonso, S Rahmouni, K Nika, M Rostamkhani, ... Nature genetics 36 (4), 337-338, 2004 | 1771 | 2004 |
| NMR in drug discovery M Pellecchia, DS Sem, K Wüthrich Nature Reviews Drug Discovery 1 (3), 211-219, 2002 | 595 | 2002 |
| Apoptosis-based therapies for hematologic malignancies JC Reed, M Pellecchia Blood 106 (2), 408-418, 2005 | 532 | 2005 |
| Perspectives on NMR in drug discovery: a technique comes of age M Pellecchia, I Bertini, D Cowburn, C Dalvit, E Giralt, W Jahnke, TL James, ... Nature Reviews Drug Discovery 7 (9), 738-745, 2008 | 509 | 2008 |
| Discovery, characterization, and structure− activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins S Kitada, M Leone, S Sareth, D Zhai, JC Reed, M Pellecchia Journal of medicinal chemistry 46 (20), 4259-4264, 2003 | 488 | 2003 |
| Role of excitatory amino acid transporter‐2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics K Kim, SG Lee, TP Kegelman, ZZ Su, SK Das, R Dash, S Dasgupta, ... Journal of cellular physiology 226 (10), 2484-2493, 2011 | 468 | 2011 |
| Apoptosis-inducing factor triggered by poly (ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia C Culmsee, C Zhu, S Landshamer, B Becattini, E Wagner, M Pellecchia, ... Journal of Neuroscience 25 (44), 10262-10272, 2005 | 444 | 2005 |
| Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins M Leone, D Zhai, S Sareth, S Kitada, JC Reed, M Pellecchia Cancer Research 63 (23), 8118-8121, 2003 | 368 | 2003 |
| A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy WJ Placzek, J Wei, S Kitada, D Zhai, JC Reed, M Pellecchia Cell death & disease 1 (5), e40-e40, 2010 | 357 | 2010 |
| Targeting the Bcl-2 family for cancer therapy S Thomas, BA Quinn, SK Das, R Dash, L Emdad, S Dasgupta, XY Wang, ... Expert opinion on therapeutic targets 17 (1), 61-75, 2013 | 316 | 2013 |
| Structural insights into substrate binding by the molecular chaperone DnaK M Pellecchia, DL Montgomery, SY Stevens, CW Vander Kooi, H Feng, ... Nature structural biology 7 (4), 298-303, 2000 | 275 | 2000 |
| NMR Structure of the J-domain and the Gly/Phe-rich Region of theEscherichia coliDnaJ Chaperone M Pellecchia, T Szyperski, D Wall, C Georgopoulos, K Wüthrich Journal of molecular biology 260 (2), 236-250, 1996 | 258 | 1996 |
| Targeting Mcl-1 for the therapy of cancer BA Quinn, R Dash, B Azab, S Sarkar, SK Das, S Kumar, RA Oyesanya, ... Expert opinion on investigational drugs 20 (10), 1397-1411, 2011 | 249 | 2011 |
| Identification of a new JNK inhibitor targeting the JNK-JIP interaction site JL Stebbins, SK De, T Machleidt, B Becattini, J Vazquez, C Kuntzen, ... Proceedings of the National Academy of Sciences 105 (43), 16809-16813, 2008 | 224 | 2008 |
| ADAR1 activation drives leukemia stem cell self-renewal by impairing Let-7 biogenesis MA Zipeto, A Sadarangani, NPD Santos, L Balaian, HJ Chun, G Pineda, ... Cell stem cell 19 (2), 177-191, 2016 | 205 | 2016 |
| Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-XL B Becattini, S Kitada, M Leone, E Monosov, S Chandler, D Zhai, TJ Kipps, ... Chemistry & biology 11 (3), 389-395, 2004 | 205 | 2004 |
| NMR structure determination of the Escherichia coli DnaJ molecular chaperone: secondary structure and backbone fold of the N-terminal region (residues 2-108) containing the … T Szyperski, M Pellecchia, D Wall, C Georgopoulos, K Wüthrich Proceedings of the National Academy of Sciences 91 (24), 11343-11347, 1994 | 195 | 1994 |
| Bcl-2 antiapoptotic family proteins and chemoresistance in cancer S Maji, S Panda, SK Samal, O Shriwas, R Rath, M Pellecchia, L Emdad, ... Advances in cancer research 137, 37-75, 2018 | 189 | 2018 |
| A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition DJ Goff, A Sadarangani, HJ Chun, CL Barrett, M Krajewska, H Leu, ... Cell stem cell 12 (3), 316-328, 2013 | 189 | 2013 |
| Bid-induced release of AIF from mitochondria causes immediate neuronal cell death S Landshamer, M Hoehn, N Barth, S Duvezin-Caubet, G Schwake, ... Cell Death & Differentiation 15 (10), 1553-1563, 2008 | 186 | 2008 |
